Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

Morten Orebo Holmström; Guy W Novotny; Jesper Petersen; Mia Aaboe-Jørgensen; Hans Carl Hasselbalch; Mads H Andersen; Signe Ledou Nielsen; Daniel El Fassi; Claudia Schöllkopf

doi:10.1080/10428194.2019.1633634

Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

Morten Orebo Holmström^*, Guy W Novotny, Jesper Petersen, Mia Aaboe-Jørgensen, Hans Carl Hasselbalch, Mads H Andersen, Signe Ledou Nielsen, Daniel El Fassi, Claudia Schöllkopf

^*Corresponding author af dette arbejde

Hæmatologisk Afdeling

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

Originalsprog	Engelsk
Sider (fra-til)	3296-3299
Antal sider	4
Tidsskrift	Leukemia and Lymphoma
Vol/bind	60
Udgave nummer	13
DOI	https://doi.org/10.1080/10428194.2019.1633634
Status	Udgivet - dec. 2019

Adgang til dokumentet

10.1080/10428194.2019.1633634

Citationsformater

Holmström, M. O., Novotny, G. W., Petersen, J., Aaboe-Jørgensen, M., Hasselbalch, H. C., Andersen, M. H., Nielsen, S. L., Fassi, D. E., & Schöllkopf, C. (2019). Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy. Leukemia and Lymphoma, 60(13), 3296-3299. https://doi.org/10.1080/10428194.2019.1633634

@article{79016fc461f94cbda881321f3ff9745c,

title = "Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy",

author = "Holmstr{\"o}m, {Morten Orebo} and Novotny, {Guy W} and Jesper Petersen and Mia Aaboe-J{\o}rgensen and Hasselbalch, {Hans Carl} and Andersen, {Mads H} and Nielsen, {Signe Ledou} and Fassi, {Daniel El} and Claudia Sch{\"o}llkopf",

year = "2019",

month = dec,

doi = "10.1080/10428194.2019.1633634",

language = "English",

volume = "60",

pages = "3296--3299",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "13",

}

Holmström, MO, Novotny, GW, Petersen, J, Aaboe-Jørgensen, M, Hasselbalch, HC, Andersen, MH, Nielsen, SL, Fassi, DE & Schöllkopf, C 2019, 'Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy', Leukemia and Lymphoma, bind 60, nr. 13, s. 3296-3299. https://doi.org/10.1080/10428194.2019.1633634

TY - JOUR

T1 - Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

AU - Holmström, Morten Orebo

AU - Novotny, Guy W

AU - Petersen, Jesper

AU - Aaboe-Jørgensen, Mia

AU - Hasselbalch, Hans Carl

AU - Andersen, Mads H

AU - Nielsen, Signe Ledou

AU - Fassi, Daniel El

AU - Schöllkopf, Claudia

PY - 2019/12

Y1 - 2019/12

U2 - 10.1080/10428194.2019.1633634

DO - 10.1080/10428194.2019.1633634

M3 - Article

C2 - 31256699

SN - 1042-8194

VL - 60

SP - 3296

EP - 3299

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 13

ER -